scholarly journals Editorial: Glyphosate Herbicide as Endocrine Disruptor and Probable Human Carcinogen: Current Knowledge and Future Direction

2021 ◽  
Vol 12 ◽  
Author(s):  
Virginia Lorenz ◽  
María Florencia Rossetti ◽  
Eliane Dallegrave ◽  
María Mercedes Milesi ◽  
Jorgelina Varayoud
2009 ◽  
Vol 618-619 ◽  
pp. 291-294 ◽  
Author(s):  
Alexander Buddery ◽  
Matthew S. Dargusch ◽  
David H. StJohn ◽  
John Drennan ◽  
Samih Nabulsi

This paper outlines the current state of research into laser welding of titanium and its alloys for medical applications. The differences that exist between the medical and other industries are described and a direction for advancing research in this field is proposed.


Author(s):  
Anita Chehri ◽  
Reza Yarani ◽  
Zahra Yousefi ◽  
Tannaz Novin Bahador ◽  
Seyed Kazem Shakouri ◽  
...  

Processes ◽  
2020 ◽  
Vol 8 (5) ◽  
pp. 541 ◽  
Author(s):  
Patricia de Faria Lainetti ◽  
Fernanda Zuliani ◽  
Antonio Fernando Leis-Filho ◽  
Ricardo Henrique Fonseca Alves ◽  
Carlos Eduardo Fonseca-Alves

Controlled drug delivery systems can be used to carry several anticancer agents, including classical chemotherapeutic agents such as doxorubicin, paclitaxel or cisplatin, and are also used for the encapsulation of tyrosine kinase inhibitors and monoclonal antibodies. Usually, the controlled systems are used to decrease drug toxicity, increase local drug concentration or target specific organs or systems. In dogs, liposomal doxorubicin is the most known controlled drug delivery vehicle in veterinary medicine. However, several antitumor drugs can be encapsulated within these systems. Since the delivery vehicles are a relatively new topic in veterinary oncology, this review aims to discuss the current knowledge regarding the controlled drug delivery vehicles and discuss the current challenges and future direction of its use in veterinary oncology.


2009 ◽  
Vol 3 (6) ◽  
pp. 1261-1269 ◽  
Author(s):  
Ann M. Sheehy ◽  
Robert A. Gabbay

Perioperative hyperglycemia is a common phenomenon affecting patients both with and without a known prior history of diabetes. Despite an exponential rise in publications and studies of inpatient hyperglycemia over the last decade, many questions still exist as to what defines optimal care of these patients. Initial enthusiasm for tight glycemic control has waned as the unanticipated reality of hypoglycemia and mortality has been realized in some prospective studies. The recent dramatic modification of national practice guidelines to endorse more modest inpatient glycemic targets highlights the dynamic nature of current knowledge as the next decade approaches. This review discusses perioperative hyperglycemia and the categories of patients affected by it. It reviews current recommendations for ambulatory diabetes screening and its importance in preoperative patient care. Finally, it concludes with a review of current practice guidelines, as well as a discussion of future direction and goals for inpatient perioperative glycemic control.


2010 ◽  
Vol 4 (8) ◽  
pp. 111 ◽  
Author(s):  
V Kalaiselvan ◽  
M Kalaivani ◽  
A Vijayakumar ◽  
K Sureshkumar ◽  
K Venkateskumar

Marine Drugs ◽  
2021 ◽  
Vol 19 (8) ◽  
pp. 466
Author(s):  
Rozita Madadi ◽  
Hamid Maljaee ◽  
Luísa S. Serafim ◽  
Sónia P. M. Ventura

Biopolymers are very favorable materials produced by living organisms, with interesting properties such as biodegradability, renewability, and biocompatibility. Biopolymers have been recently considered to compete with fossil-based polymeric materials, which rase several environmental concerns. Biobased plastics are receiving growing interest for many applications including electronics, medical devices, food packaging, and energy. Biopolymers can be produced from biological sources such as plants, animals, agricultural wastes, and microbes. Studies suggest that microalgae and cyanobacteria are two of the promising sources of polyhydroxyalkanoates (PHAs), cellulose, carbohydrates (particularly starch), and proteins, as the major components of microalgae (and of certain cyanobacteria) for producing bioplastics. This review aims to summarize the potential of microalgal PHAs, polysaccharides, and proteins for bioplastic production. The findings of this review give insight into current knowledge and future direction in microalgal-based bioplastic production considering a circular economy approach. The current review is divided into three main topics, namely (i) the analysis of the main types and properties of bioplastic monomers, blends, and composites; (ii) the cultivation process to optimize the microalgae growth and accumulation of important biobased compounds to produce bioplastics; and (iii) a critical analysis of the future perspectives on the field.


2017 ◽  
Vol 197 (2) ◽  
pp. 287-295 ◽  
Author(s):  
Grant P. Redrow ◽  
Charles C. Guo ◽  
Maurizio A. Brausi ◽  
Jonathan A. Coleman ◽  
Mario I. Fernandez ◽  
...  

2017 ◽  
Vol 26 (4) ◽  
pp. 323-330 ◽  
Author(s):  
Pyi Naing ◽  
Harveen Kuppusamy ◽  
Gregory Scalia ◽  
Graham S. Hillis ◽  
David Playford

Lupus ◽  
2018 ◽  
Vol 27 (12) ◽  
pp. 1881-1897 ◽  
Author(s):  
P D Sattwika ◽  
R Mustafa ◽  
A Paramaiswari ◽  
E H Herningtyas

Lupus nephritis (LN), a common manifestation of systemic lupus erythematosus (SLE), accounts for significant morbidity and mortality in SLE patients. Since the available standard therapies and biologic agents for LN are yet to achieve the desired response and have considerable secondary effects, stem cell therapy has now emerged as a new approach. This therapy involves the transplantation of hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs). Our current review will highlight the progress of stem cell therapy for LN, along with the challenges encountered and the future direction of this approach.


Sign in / Sign up

Export Citation Format

Share Document